This was not corroborated by a different study that assessed the effect of iron infusion in haemodialysis patients with anaemia and adequate iron stores (the DRIVE study) which showed that increased iron supplementation above target levels improved Hb response [27]. The gene discussed is GSTM1; the disease is anemia.